BOLT - Bolt Biotherapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BOLT is currently covered by 1 analysts with an average price target of $7. This is a potential upside of $63.04 (75.88%) from yesterday's end of day stock price of $3.98.

Bolt Biotherapeutics's activity chart (see below) currently has 4 price targets and 11 ratings on display. The stock rating distribution of BOLT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.96% with an average time for these price targets to be met of 29.56 days.

Highest price target for BOLT is $7, Lowest price target is $7, average price target is $7.

Most recent stock forecast was given by from HC WAINWRIGHT on 28-May-2026. First documented stock forecast 02-Mar-2021.

Currently out of the existing stock ratings of BOLT, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Oct-2025

$7

$2.72 (63.55%)

$7

3 months 18 days ago
(28-May-2026)

1/3 (33.33%)

$1.7 (32.08%)

99

Hold Since 03-Sep-2025

$6

$1.72 (40.19%)

1 years 12 days ago
(03-Sep-2025)

1/4 (25%)

$1.16 (23.97%)

34

Buy Since 15-Aug-2025

$75

$70.62 (1612.33%)

1 years 1 months ago
(15-Aug-2025)

0/1 (0%)

$69.85 (1356.31%)

Hold Since 15-May-2024

1 years 5 months 21 days ago
(25-Mar-2025)

0/3 (0%)

$126.4 (376.19%)

Hold Since 15-May-2024

$30

$25.24 (530.25%)

2 years 4 months ago
(15-May-2024)

0/2 (0%)

$13.4 (80.72%)

Show more analysts

Please expand the browser size to see the chart

What is BOLT (Bolt Biotherapeutics) average time for price targets to be met?

On average it took 30 days for the stock forecasts to be reached, with an average price target met ratio of 12.96%.

Which analyst most recently updated their price target on BOLT (Bolt Biotherapeutics)?

Which analyst has the most public recommendations on BOLT (Bolt Biotherapeutics)?

has 0 price targets and 0 ratings on BOLT

Which analyst is the currently most bullish on BOLT (Bolt Biotherapeutics)?

Chad Messer with the highest potential upside of $70.62

Which analyst is the currently most reserved on BOLT (Bolt Biotherapeutics)?

Matthew Harrison with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?